ASHP InterSections ASHP InterSections

September 8, 2021

Pharmacists at the Helm of Pharmacogenomics Efforts

Pat Peters and his daughter, Trish Brown

AFTER SUFFERING A HEART ATTACK IN 2014, Pat Peters needed a percutaneous coronary intervention (PCI) – a procedure that many Americans undergo each year. However, unlike most other patients, Peters was lucky to have a seasoned genetic counselor and pharmacogenomics advocate by his side.

Pharmacogenomics Impact

“When my dad’s physician placed an order for clopidogrel as antiplatelet therapy, I knew from a pharmacogenomics test that he was one of the [small number] of the population that are CYP2C19 poor metabolizers, so clopidogrel would have been ineffective for him,” said Pat’s daughter, Trish Brown, who is director of AMR Payer Partnerships and Field Market Access at Illumina, a genetic sequencing company based in San Diego.

With over 20 years of experience in the genomics industry, Brown knew pharmacogenomics could immensely improve treatment decisions and improve the likelihood a drug will be safe and effective. With that in mind, she had her father’s genome preemptively tested for known gene-drug pairs. When it came time for the discussion with the cardiologist about post-PCI antiplatelet therapy, Brown informed the physician of her father’s CYP2C19 status.

“Thankfully, the cardiologist accepted the genomic results and chose an alternative agent, but unfortunately, there was no place to include the test results in the EHR other than as a PDF attached to a clinical encounter, where it would really just sit and not be seen,” Brown said, noting the hospital also did not have any staff that knew how to order or interpret genetic test results.

Pioneering Pharmacogenomics

Peters’ experience stands in contrast to the care pharmacists at St. Jude Children’s Research Hospital in Memphis, Tennessee, help provide. For the past 30 years, pharmacists have been incorporating pharmacogenomics results to help their physicians make the best treatment decisions possible.

Mary Relling, Pharm.D.

Although the hospital’s patient population is almost entirely pediatric, there was one instance where pharmacogenomics proved invaluable when a patient needed antiplatelet therapy, explained Mary Relling, Pharm.D., who holds an endowed chair in the Department of Pharmacy and Pharmaceutical Sciences at the hospital.

“This particular patient was ordered clopidogrel, and we had tested her CYP2C19 status in advance and found she lacked the gene needed to activate clopidogrel. Thus the drug would have been ineffective for preventing stroke,” said Dr. Relling, who spoke during a Pharmacogenomics Virtual Summit jointly organized by ASHP and the American Medical Association.

Avoiding potentially ineffective care in this patient “goes to show that while it’s usually a minority of the population that has a high-risk genotype, for that small percentage of patients, pharmacogenomics testing can yield a really big benefit,” she said.

Pharmacogenomics is deeply embedded at St. Jude, with Dr. Relling and her team regularly testing for genes like thiopurine methyltransferase (TPMT) and CYP2D6, which affect the metabolism of medications more commonly used there, like thiopurines for leukemia and codeine for pain.

Implementing Actionable Findings

Since 2011, pharmacists at St. Jude leading the PG4KDS program have tested for hundreds of gene variants and used those genetic data to improve medication efficacy and safety outcomes. They have so far enrolled nearly 6,000 patients and implemented 14 genes affecting 66 drugs, Dr. Relling said.

“We want to implement as many actionable findings into the electronic health record as we can, along with decision support tools, and we want to provide specific recommendations to help make better treatment decisions,” explained Dr. Relling.

One of Dr. Relling’s most significant contributions to the field of pharmacogenomics was co-founding the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009. The 400 members of CPIC, from 269 institutions in 36 countries, generate peer-reviewed and evidence-based guidelines for providers, pharmacists, and laboratories to follow.

“We want to make these guidelines freely available to whichever institutions and laboratories want to incorporate pharmacogenomics into routine care,” Dr. Relling said. She noted that while institutions using pharmacogenomics are in the minority today, “the number is slowly growing.”

Incorporating Findings in the EHR

While Dr. Relling and her CPIC partners are developing guidelines for pharmacogenomics-based decision making, affiliates of the Implementing Genomics in Practice (IGNITE) Consortium are focusing on how best to incorporate and implement these results into the healthcare workflow.

At the University of Alabama at Birmingham School of Medicine, which is an IGNITE affiliate, Nita Limdi, Pharm.D., Ph.D., MSPH, director of the program for translational pharmacogenomics and associate director of the Hugh Kaul Precision Medicine Institute, and her colleagues are documenting what they believe will be better outcomes when genomic information is used to guide the treatment of patients like Pat Brown undergoing PCI.

To improve the chances that pharmacogenomics results are integrated into the treatment decision-making process, Dr. Limdi and a health system informatics team are developing a “genomic medicine landing page” in their EHR, where pharmacogenomic results and recommendations will be housed.

“Our position has always been that once you find something that is important to patient care, you put it in the hands of clinicians,” said Dr. Limdi, an ASHP member.

Preemptive Whole Panel Testing

Dr. Limdi hopes to further expand use of pharmacogenomics at her institution through in-house whole-panel preemptive and reactive testing. She and her team are in the process of validating the system and plan to offer it to all hospital service lines.

Nita Limdi, Pharm.D., Ph.D., MSPH

“While most testing has been done reactively— for a patient who has not responded to treatment with an antidepressant, for example — I believe it will become fairly routine to do whole-panel testing preemptively,”Dr. Limdi said.

Dr. Limdi’s conviction that pharmacogenomics holds great value is partly rooted in her experience as a pharmacist specializing in neurosciences, when she observed patients inconsistently responding to drugs like warfarin and anti-epileptics.

“Coming from that service line gave me a really deep appreciation for how much of the variability in drug response can be accounted for by genomic factors and how useful it is to have that genomic information in the patient’s record,” she said.

Pharmacogenomics Pharmacist Teams

In another effort to increase the use of pharmacogenomics at her institution, Dr. Limdi is building a team of specialized pharmacogenomics pharmacists who will lead testing efforts at her hospital. An innovative part of the model is that these pharmacogenomics pharmacists will mentor clinical pharmacists in the use of pharmacogenomics as it applies to their specialty.

“The idea is to have our pharmacogenomics service line start by doing all the initial genotype interpretation and consults, but as they hand off those results to clinical pharmacists embedded in different units, they will also shepherd them so they can be proficient in interpreting results on their own,” said Dr. Limdi.

If the model proves successful, it could be adopted at other institutions to integrate pharmacogenomics testing into routine clinical care, she suggested. As the demand for pharmacogenomics services increases, a highly specialized pharmacogenomics service team would be free to manage more complex cases, such as those with polygenic drug response signatures.

Pharmacogenomics programs like those at St. Jude’s and the University of Alabama are only two examples of the initiatives pharmacists are leading across the country. Dr.  Limdi believes this is an area of care that will grow tremendously in the coming years. “This is very much an evolving field, and I’m really excited about the possibilities it will bring,” she said.

 

By David Wild

August 26, 2021

Johnnie L. Early II and Peter H. Vlasses Named Honorary Members of ASHP

Dr. Johnnie L. Early II, R.Ph., Ph.D., FNPhA

TWO PHARMACY LEADERS WITH A PASSION for education have been presented with Honorary Membership Awards by the ASHP Board of Directors.

The awards, which recognize individuals who have made outstanding contributions to pharmacy practice, were given to Johnnie L. Early II, R.Ph., Ph.D., FNPhA, dean of Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, in Tallahassee, and to Peter H. Vlasses, Pharm.D., D.Sc. (Hon.), FCCP, executive director emeritus of the Accreditation Council for Pharmacy Education (ACPE) in Chicago. Both were elected for life by unanimous vote.

A lifetime of pharmacy leadership

Dr. Early was recognized for his nearly four decades of pharmacy education and his dedication to expanding opportunities for youth from various racial and ethnic backgrounds to explore careers in pharmacy practice and the pharmaceutical sciences. A charter member of the Student National Pharmaceutical Association (SNPhA), Dr. Early has worked tirelessly to recruit diverse students and create more diverse workforces at the several universities he has worked for. He is the recipient of numerous awards for his contributions to pharmacy, including the 2018 ASHP-ABHP Joint Leadership Award, the Outstanding Alumnus Award from the Purdue University chapter of the SNPhA, the National Pharmaceutical Association’s Chauncey I. Copper Award, and the ABHP Wendell T. Hill Award. He also was among the first to be honored as a Fellow of the National Pharmaceutical Association.

Dr. Early “is a distinguished educator and visionary leader in pharmacy,” ASHP said a formal announcement. “He has been instrumental in addressing racial disparities in healthcare, expanding opportunities for BIPOC youth to explore careers in pharmacy practice and the pharmaceutical sciences, and developing a more diverse and culturally competent healthcare workforce.”

Home grown brew    

Growing up, Dr. Early said he always had an interest in science and science fiction. But his first memory of being impressed by pharmacology was around age 5. He was sick, and laying in his bed, when his maternal grandmother came to the house and asked what was wrong. She felt his forehead, then went to the kitchen and rummaged through the knife drawer. The sound piqued Dr. Early’s curiosity (“The first thing I thought was surgery,” he laughed). Instead, his grandmother went out to the front yard, cut some leaves off a plant, and brewed him a warm, bitter tea to drink. Within 30 minutes or so, he felt better.

Years later, Dr. Early considered a variety of careers in the health sciences. As an undergraduate biology major at Fort Valley State University in Georgia, he was one of several students recruited directly by the dean of Mercer University Southern School of Pharmacy, Dr. Oliver Littlejohn. The day he started pharmacy school he was also invited to be interviewed for medical school.  He explored public health and took the Dental Aptitude test where he was asked to carve a piece of chalk. Despite his dexterity, the chalk broke, and his career in pharmacy began. After graduating from Mercer, Dr. Early went on to receive his master’s and Ph.D. degrees in pharmacology/toxicity from Purdue University.

A dedication to academics

Dr. Early has had a long academic career, holding several positions at Florida A&M including program director of the Minority Biomedical Research Support Program, assistant dean for research, and dean. He then served as dean and professor for the Medical University of South Carolina and for the University of Toledo, in Ohio, before returning to Florida A&M in 2018 for his current role.

Inspired by the dean who recruited him to pharmacy school, Dr. Early has made a point of recruiting potential trainees in person when possible. Over the past two decades, he has established programs at the University of Toledo and at Florida A&M through which minority high school students spend a few days on campus learning more about pharmacy and pharmaceutical sciences careers. Last year, due to the COVID-19 pandemic, the course was shortened and put online, but students still got some hands-on experience, including making capsules.

“I’m a guy who likes to work,” he said. “And I’m always trying to figure out how to make my people and programs better. Every time somebody gets hired with us, and then is promoted and moves on to higher positions, I see that not as a loss but as an applause for the program.”

Grateful and humbled          

Dr. Early, who started attending ASHP meetings when he first became dean of Florida A&M in 1987, said he was floored to receive a call from ASHP CEO Paul Abramowitz, Pharm.D., Sc.D. (Hon), FASHP, letting him know of the honorary membership award. “It was not in my thinking that that kind of award would be anything that would come my way,” he said. He thanked Dr. Abramowitz on the phone and, in his signature style, later in a handwritten note. “It’s a most significant award, and something that I’m ever so grateful for.”

Longtime pharmacy education leader

Dr. Vlasses was honored for his nearly 45 years in the pharmacy profession. During his 20-year tenure at ACPE, he oversaw the accreditation of the professional degree program in pharmacy; strengthened continuing professional education and development for pharmacists and pharmacy technicians; and championed interprofessional collaboration in education and accreditation. He also led the establishment of the ACPE International Services Program and supported its reach to improve pharmacy education and training worldwide.

Dr. Peter H. Vlasses, Pharm.D., D.Sc. (Hon.), FCCP

In 2014, Dr. Vlasses joined forces with ASHP to create the Pharmacy Technician Accreditation Commission (PTAC) to assure and advance the quality of pharmacy technician education and training programs. He has received numerous honors including the American Association of Colleges of Pharmacy’s Board of Directors Distinguished Service Award and the National Center for Interprofessional Practice and Education Pioneer Award.

“Dr. Vlasses is a prominent leader in pharmacy who was a significant ASHP partner in developing the ASHP/ACPE national accreditation standards for pharmacy technician education and training programs,” ASHP said a formal announcement. “His vision, commitment, and collaborative leadership have helped strengthen the foundation of excellence in accreditation of the education of pharmacists and pharmacy technicians in the United States and around the world.”

A desire to change the world

Dr. Vlasses’ parents were Greek immigrants. As the older of two sons, he was expected to take over the family’s restaurant/bar and liquor store in Camden, N.J. This was in the 1960s, when young people were talking about changing the world and working to serve others. Dr. Vlasses said he didn’t see the liquor store/bar part of the business as helping, so he reluctantly approached his father and asked about pursuing college and a profession.

Instead of being upset, his father talked through three career choices with him. They ruled out medicine because Dr. Vlasses was squeamish around blood. They ruled out law because as a native Greek speaker, he had some challenges with English. But a family friend was a pharmacist with his own store. After a visit, Dr. Vlasses chose to study pharmacy, enrolling at Philadelphia College of Pharmacy and Science. He attended his first ASHP Midyear Clinical Meeting as a student in 1970, when pharmacy education was starting to change. After receiving his bachelor’s degree in pharmacy, Dr. Vlasses completed a one-year hospital pharmacy residency at Thomas Jefferson University Hospital and then completed his Pharm.D. education at the Philadelphia College of Pharmacy and Science.

Passion for research and academia

Dr. Vlasses then spent many years in academia, working for Ohio State, the Philadelphia College of Pharmacy and Science, and Jefferson Medical College in Philadelphia. He got involved in research and was elected president of the American College of Clinical Pharmacy. At the time, there was some controversy over whether pharmacists could be clinical investigators on research trials. He wrote to the Food and Drug Administration to inquire if that was permitted; the agency said it was.

“A lot of people subsequently told me that letter helped them do research and get funding,” he said. “That was something I always valued that I contributed to the profession.”

During that time, Dr. Vlasses also became more involved with professional organizations including ASHP, serving on the Council on Therapeutics and on the Research and Education Foundation and Awards program, before moving to ACPE in 1999. Not only did he help develop PTAC seeing that pharmacy technicians needed better training, but when he joined the organization, he worked to improve accredited continuing education standards for continuing education for pharmacy technicians.  providers in pharmacy who were also committed to interprofessional continuing education.

Interprofessional collaboration

“When I joined ACPE, I saw medical professionals learning in silos—doctors in medical school, nurses in nursing school, etc.,” he said. “There wasn’t a lot of interactions to say we’re on the same team, we should learn and practice together, and everybody should contribute at the top of their license.”

Dr. Vlasses worked to change the accreditation standards for pharmacy degree programs so students were “team ready” at graduation, with education in the classroom, clinical experience, and exposed to interprofessional education in practice. Similarly, he worked with accreditor colleagues from other health professions to improve accredited continuing education standards to facilitate team-based continuing education, “planned by the team and for the team.” He initially developed joint CE accreditation standards for pharmacy, nursing and medicine. That has since grown to include acceptance by accreditors for CE accreditors for athletic trainers, dentists, dietitians, optometrists, physician assistants, psychologists, and social workers. Any combination of those trainees can learn together and receive CE credit in their professional as well as interprofessional CE credit.

Living the American dream  

Dr. Vlasses retired in 2019. He said when he received the call from Dr. Abramowitz about the honorary membership award, “I was very much honored that ASHP and the board would see me in that light, and valued the contributions I have made as a member of the organization and as a pharmacist. Starting out as a son of a Greek immigrant and the first college graduate in my family to being able to be recognized by a number of pharmacy organizations and ASHP was in many cases the American dream for me.”

 

By Karen Blum

 

April 23, 2021

Hospital Pharmacy Leader Makes Mentorship a Top Priority

Vickie Powell, Pharm.D., M.S., FASHP

WITH A PASSION FOR MENTORSHIP and a dedication to her community and the pharmacy profession, Vickie Powell, Pharm.D., M.S., FASHP, is a pharmacist to emulate. Dr. Powell, site director of pharmacy for New York-Presbyterian Hospital, first thought about a pharmacy career during high school, where she had an interest in and maintained good grades in science. A guest speaker encouraged her and some of her high-achieving classmates to pursue careers in the medical field.

“I did not want to be a doctor because I didn’t like blood,” she said. “I didn’t want to be a dentist. So I thought pharmacy would be the best profession for me because I wouldn’t have to come in contact with all of those things. I love pharmacy. I’m glad I took that path.”

After completing pharmacy school at Xavier University of Louisiana in New Orleans, Dr. Powell got married and moved to New York City’s Harlem neighborhood, where she took a pharmacist position at a drug store downstairs from her apartment. While she found it rewarding working in the community, she wanted to do more. Then one of her customers, a pharmacy director at Harlem Hospital, encouraged her to try hospital pharmacy.

Dr. Powell applied for and was offered a registered pharmacist job with St. Luke’s/Roosevelt Hospital Center. She threw herself into work with enthusiasm, volunteering for everything from backing up computerized pharmacy records to learning all about then-upcoming USP <797> regulations and developing plans for a compliant I.V. room. She soon moved up to an inpatient pharmacy supervisor and developed numerous specialty satellite pharmacies throughout the hospital.

Valuable Mentorship

Because of her expertise, Dr. Powell found herself giving talks to the New York City Society of Health-System Pharmacists. At first, she wasn’t sure how to balance work and being involved in professional pharmacy societies with family life. But her supervisor and mentor, Harvey Maldow, R.Ph., believed it was so important she participate that he told Dr. Powell’s husband that he had to watch their young children while she attended meetings. She became the second African-American president of the group.

During her acceptance speech, Dr. Powell discussed mentoring and her philosophy of “Each one, teach one,” based on every mentee helping pull up someone behind them. The vice president of pharmacy at New York-Presbyterian Hospital was impressed and approached her about a director job. Maldow encouraged her to apply.

Today, Dr. Powell oversees pharmacy operations for three of the health system’s 11 hospitals, and oversees around 600 pharmacy employees. Besides her work tasks, Powell continues to make mentoring a priority, promoting good communication skills and lifelong education. She’s proud to have encouraged many technicians to become pharmacists.

“We meet on a regular basis because I don’t want to just tell people something and then hope they’ll follow it through; I try to work with them one-on-one to help them achieve whatever goals we’ve set out for them,” she said.

Community Service

Dr. Powell also maintains close ties to her community, serving for many years as a Sunday school teacher and member of the health committee at her church. Powell brings in guest speakers on topics important to their membership, such as hypertension and diabetes. One speaker, celebrity cardiothoracic surgeon Mehmet Oz (TV’s “Dr. Oz”), awarded free gym memberships to a few audience members. She also has been a special events coordinator for the Harlem Little League. More recently, Powell supervised a COVID-19 vaccine clinic at her church run by her hospital.

“I try to do a lot of things to help our community, and I do whatever I can to propel the practice of pharmacy,” she said. To that end, Dr. Powell serves on the Board of Directors for Long Island University’s College of Pharmacy and has given guest lectures at Touro College of Pharmacy. In 2009, she was the first African-American president of the New York State Council of Health-System Pharmacists.

ASHP Leadership       

Dr. Powell also has been very active in ASHP, serving over the years as a delegate as well as on several committees, including the Council on Education and Workforce Development and the Committee on Nominations. In 2020, Dr. Powell was honored to be invited to join ASHP’s Task Force on Racial Diversity, Equity, and Inclusion.

Dr. Powell and her colleagues celebrate receiving the first dose of the COVID-19 vaccine.

“Our social and justice systems are broken, and conscious and unconscious racism exists,” she said. “We talked a lot about institutional racism, which sometimes has been embedded as a normal practice within a society or organization. We made some changes in the structure of how things will be done to assure equity for all members. I don’t think people realize how institutional racism can lead to such issues as discrimination in employment, health care, and even with access to the [COVID-19] vaccine.”

The group suggested some changes to ASHP policies, Dr. Powell said, one being that a person can only run for a board position if they had just been a delegate. “That eliminates a lot of people,” she said. The group recommended that members did not have to have delegate experience to run for a board office. They also changed governance so the chair of the house of delegates no longer presides over the nominations committee, which could be a conflict of interest.

“We opened it up so that more people would have the opportunity to run for office,” she said. “We’re going to make mentoring a big part of the process.”

Dr. Powell stands out because of her intelligence, her mentorship, her compassion, and her ability to listen to people and understand their needs, Maldow noted.

“She’s one of the best people I ever worked with in terms of how she managed both down and up, and the staff adored her,” he said. “When I look at the people I mentored in my career, she’s on the top in how successful she has been, and it’s a credit to her, not me. The only thing I take credit for is being able to identify her potential. She’s a great health-system pharmacist and someone people should model themselves after.”

 

By Karen Blum

March 17, 2021

Kurt Kleinmann: From WW2 Refugee to Pharmacy Innovator

The Kleinmann family in April 1938. Left to right: Herta, Gustav, Kurt, Fritz, Tini, Edith

PIONEERING PHARMACIST KURT KLEINMANN, R.PH., HAS SEEN the worst and best sides of humanity. In 1938, as Hitler rose to power in Europe, his family was among the millions of others to bear the brunt of a growing tsunami of anti-Semitism.

“I remember as a child in Vienna having a Hitler youth push my head into the snow,” recalled Kleinmann, now 91 years of age. The Kleinmann family’s situation worsened in 1939 when his father, Gustav, and his older brother, Fritz, were arrested and sent to the Buchenwald concentration camp in Germany and eventually to the Auschwitz concentration camp.

Then in 1942, Kleinmann’s mother, Tina, and his sister, Herta, were rounded up and shipped to Minsk. Kleinmann’s father and brother survived seven years of forced labor at the concentration camps, but his mother and sister were killed three days after arriving in Minsk.

Fortunately for Kleinmann and his elder sister, their mother had the foresight to send them both off to the United States and England, respectively. This heart-wrenching decision was likely made knowing she may never see her children again.

Arrival in the States

Kleinmann’s time in Europe, which is written about in a recent book titled “The Boy Who Followed His Father into Auschwitz,” was the dark side of humanity, but when he arrived in the United States at age 11, Kleinmann was shown a level of generosity that he has reciprocated in equal measure, both inside and outside of his profession.

“I was taken in by a wonderful family in New Bedford, Massachusetts, and they really saved my life,” Kleinmann said. “Judge Samuel Barnet and his three sisters became like a new father and three new mothers. I always kidded that I had to behave so as not to spoil their reputation.”

Kleinmann was given all the opportunities that a child his age could hope for: summer camp and afternoons playing baseball, “which I enjoyed even though I wasn’t good enough to make the high school team,” he said.

As a high school student, Kleinmann set his sights on a career in aeronautical engineering but soon realized that pursuing this path required an element of tedium that wasn’t for him.

“My high school counselor said I needed to take mechanical drawing if I wanted to become an aeronautical engineer. The first nine weeks of the class were very boring and involved perfecting your handwriting, writing the letters of the alphabet over and over and over again in lower case and upper case,” Kleinmann recalled.

When he spoke to his counselor about dropping the course, she reiterated that mechanical drawing was a requisite for college studies in aeronautical engineering.

“I looked at her and said, ‘ok, so I’ll become a pharmacist!’ and that’s how I ended up with a wonderful career which I’ve loved ever since,” Kleinmann said.

Pharmacy Studies Interrupted by Military Service

Kleinmann spent 16 months as a hospital pharmacist in the military.

Kleinmann completed his undergraduate pharmacy studies in 1952 at what was then the Rhode Island College of Pharmacy, continuing on to graduate studies at Ohio State University with the intention of getting a job in pharmaceutical manufacturing. However, a year into the program, Kleinmann was drafted into military service and sent to Germany and Austria, where he spent 16 months as a hospital pharmacist.

The experience left him wanting to work in hospitals rather than industrial manufacturing. Kleinmann, who had applied for a residency at the Johns Hopkins Hospital prior to serving in the military, was offered a staff position in the pharmacy department on his return to the United States. He took up the offer and was eventually promoted to serve as the supervisor of their compounding operations. After two years there, Kleinmann decided he needed to get back on track with graduate-level hospital pharmacy studies.

He was accepted to the St. Louis College of Pharmacy’s residency program. He completed a placement at the St. Louis VA Medical Center–John Cochran Division, where he got a flavor of the possibilities within hospital pharmacy.

“My preceptor wrote a letter to every hospital in St. Louis saying, ‘I have a resident here, and I’d be happy to share him with you for a month, and you can work him as hard as you want, but you have to teach him something,’” Kleinmann recounted.

Big Break

It was at the tail end of his residency that Kleinmann had a career-boosting meeting with Paul Parker, a pioneer in hospital pharmacy who at the time was the executive secretary for ASHP, then known as the American Society of Hospital Pharmacists.

“Paul was asked to man the ASHP booth on his own at a convention for the Catholic Hospital Association, which had their headquarters in St. Louis, and my preceptor knew Paul and sent me to keep him company at the booth,” Kleinmann said.

The new graduate left a strong impression on Parker. After the meeting, the elder pharmacist introduced his colleagues at Grant Medical Center in Columbus, Ohio, to Kleinmann because they were searching for a new pharmacy director.

“Paul had received a call from the hospital administrator at Grant that they were seeking a new pharmacy director. He indicated to them, ‘I just met a young fellow in St. Louis, and you should give him a call,’” Kleinmann recounted.

Innovator

Kleinmann was hired for the job and went on to develop their pharmacy program. He and was also given the freedom to flex his muscles as an innovator. “In those early days, doctors on the floor wrote medication orders in the patient’s chart, and nurses would copy those by hand and send the copies to the pharmacy,” Kleinmann explained. “Needless to say, there were numerous transcribing errors and dispensing errors.”

Kleinmann has become a beacon of light to those around him.

To improve the safety of the prescribing process, in 1965, Kleinmann developed a standardized approach for physicians to send their original orders directly to the pharmacy. The published protocol touched on everything from the essential components of an order form to considerations around the color of the paper being used.

Marvin Lew, M.S., who worked at Montefiore Medical Center in New York, with Kleinmann during his 30 years as pharmacy director there, said Kleinmann was relentless in his efforts to advance the profession of hospital pharmacy.

“Kurt pushed innovative programs year after year, and when a project was successfully completed, we would all breathe a sigh of relief and say how thankful we were that it was over, only to find out there was an even greater project for the upcoming year,” he said.

Recognition

Kleinmann’s order entry innovation won him national recognition, and he was invited by ASHP to do a speaking tour across the country. Nearly 30 years later, Kleinmann’s ongoing contributions – including early advocacy for pharmacy specialization and greater pharmacist involvement in the continuum of care – were again recognized by ASHP, this time through the prestigious Harvey A.K. Whitney Lecture Award.

“ASHP and I have been very good partners,” Kleinmann told ASHP InterSections. “In fact, if you make a list of every committee that ASHP ever had, at one time or another, I chaired it.”

Giving Back to the Refugee Community

During his time at Montefiore Medical Center, Kleinmann also had the opportunity to pay forward the generosity he received from Judge Barnet when he arrived in the United States. While working at Montefiore, Kleinmann helped refugees from the former Soviet Union who had been nurses and doctors to re-integrate into the healthcare field in the United States.

“They did not meet the licensure requirements to practice their profession in the States, but I developed a program where they received English lessons at the local college and then completed a 10-week technician training program,” said Kleinmann. “I was able to place most, if not all, of these individuals at hospitals in the metropolitan New York area, where they re-entered the health care workforce and gave hospitals and pharmacy directors the chance to augment their pharmacy program.”

As Kleinmann’s list of deeds shows, despite his direct experience with the sinister side of humanity during his childhood, he has not only transcended the effects of the Holocaust, he has become a beacon of light for those around him.

“I can honestly say that if one were in Kurt’s presence and were willing to meet him halfway, he would make them a better individual and person,” said Lew, Kleinmann’s former colleague. “Indeed, being close to him on a daily basis for many years made me a happier and more positive person.”

An ASHP news article provides additional details about Kleinmann’s family and their experiences in Nazi Germany.

By David Wild

February 17, 2021

Pharmacy Leader Promotes Diversity, Mentorship, and Community Service

Vivian Bradley Johnson, Pharm.D., M.B.A., FASHP

On her 60th birthday, Vivian Bradley Johnson, Pharm.D., M.B.A., FASHP, senior vice president of clinical services at Parkland Health and Hospital System in Dallas, performed the kind of selfless acts that have marked her career to date.

“I wanted essential workers to know how much I appreciated the work they’ve been doing during the pandemic, so I gave them certificates and gift cards, and I also prepared baskets for the homeless and the elderly,” she said. “It was a full day all about others, not me.”

A life of service is what brought Dr. Johnson to pharmacy in the first place. Originally from Lake City, Florida, she was inspired by several members of her community, including a couple of retail pharmacists her family entrusted with their health, and a Black community pharmacist within her church whom she admired.

Thirty-five years after starting out as a practicing pharmacist, Dr. Johnson has become an ASHP fellow with a career distinguished by numerous successful initiatives. For example, she helped launch ASHP’s investigational drug service network after identifying a need for such a group.

Since taking up employment at Parkland Health and Hospital System, Dr. Johnson established the health system’s first central fill pharmacy, which processes 6,000 outpatient prescriptions daily. She also developed several medication safety programs, created a variety of pharmacist-led clinical initiatives, and helped bring pharmacists to the patients’ bedside.

Pharmacist Diversity

One of Dr. Johnson’s greatest passions and a principle that has guided her work has been increasing diversity within the pharmacy workforce, among pharmacy leaders, and in academia. That focus on diversity recently earned her a spot on ASHP’s Task Force on Racial Diversity, Equity, and Inclusion (DEI), where Dr. Johnson said she is eager to help find ways to enhance ASHP’s diversity on every level, from governance to products, services, and member communication.

According to Carrie A. Berge Pharm.D., M.S., vice president of pharmacy services at Parkland Health and Hospital System, Dr. Johnson is the right person for the job, having helped ensure leadership and staff at her health system represent the community they serve.

Dr. Johnson completed her undergraduate pharmacy degree at Florida A&M University, a HBCU.

“Vivian has spoken about leadership development and diversity to the entire organization throughout her career, and she has mentored many students, residents, and college interns and supports her community through extensive work with various charitable and social organizations,” said Dr. Berge.

Something Dr. Johnson hopes to help ASHP do in the coming years is recruit more individuals from historically Black colleges and universities (HBCUs), a source of talent that Dr. Johnson said has been historically neglected.

“There’s a bias and belief that I think some people still carry, which is that the quality of education at HBCUs is not equal to other colleges and universities. I strongly disagree with that, and we need to overcome that bias,” Dr. Johnson insisted, noting that she herself completed her undergraduate pharmacy degree at Florida A&M University, a historically Black university.

While a sizeable portion of ASHP members are Black, Indigenous, and People of Color (BIPOC), Dr. Johnson said she wants to “reach out a little further to minority practitioners and students so they know how ASHP membership can benefit them.”

In addition to better communicating membership benefits, Dr. Johnson would like to offer additional services, which include helping students and young practitioners find mentorship opportunities. “I didn’t go from being a staff pharmacist to senior vice president of clinical services on my own,” she said. “It was so important for me to have leaders and mentors to guide me.”

Dr. Johnson recalled that as a new practitioner she would attend ASHP Midyear meetings with the intent of connecting and finding support from others who had been in the profession for longer. She saw this as a benefit of ASHP membership.

“I was very self-motivated and reached out to leaders in pharmacy that I looked up to, but others may not feel as comfortable approaching people, so we need to offer resources and avenues to facilitate mentorship relationships,” Dr. Johnson said.

Diversity and Patient Care

Ensuring more BIPOC community members take pharmacy leadership positions will also be critical to sharing important insights into the culture and the types of challenges that diverse communities face, Dr. Johnson noted. “We need to know where there are health care disparities and how pharmacists can help eliminate those disparities,” she said.

While pharmacists provide direct care for chronic diseases and medication therapy management, she said not everyone gets equal access to this care. “A better understanding of the populations that are at risk of being underserved and the social determinants that affect their access to resources will help us make sure they get the best possible pharmaceutical care,” Dr. Johnson said.

Pursue Your Ambitions

Although there is much more work to do to improve diversity in the pharmacy community, Dr. Johnson hopes her own career growth can inspire BIPOC students and practitioners to strive towards their ambitions, “even when it may not appear that an opportunity is there for you.”

She believes that each person should go after whatever they would like to do within the pharmacy profession. “If that means reaching out to a person you’d like as a mentor, reach out to them,” Dr. Johnson explained. “For example, if you want to write an article, take the initiative and connect with someone who has published, and ask them for help. There are leaders in pharmacy who are willing to help and guide you.”

 

By David Wild

 

# # #

 

 

November 30, 2020

ASHP’s Midyear Clinical Meeting is Unstoppable

Dear Colleagues,

The 55th Annual Midyear Clinical Meeting and Exhibition is about to kick off! We have a wonderful week ahead packed with world-class educational programming, exciting speakers, and opportunities to connect with colleagues and enrich your practice. This year’s theme is “Unstoppable,” and more than 23,000 attendees will have the opportunity to come together, Dec. 6 –10, on our virtual platform to knowledge share, network, and experience the largest gathering of pharmacists in the world in a new and unique way. Registration will remain open through Dec. 10, so there is still time to register and take advantage of everything the meeting has to offer.

We are delighted to welcome our keynote speaker, award-winning actor, producer, director, and COVID-19 survivor, Tom Hanks, on the morning of Monday, Dec. 7. We are also very pleased to welcome Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, joining us on Wednesday, Dec. 9. Please note that these special events will only be available for viewing during the scheduled session days and times. You don’t want to miss these extraordinary speakers.

The 2020 Midyear also features:

  • More than 175 hours of continuing education
  • More than 4,600 posters
  • 1,328 booths in the Residency Showcase (29% increase over 2019)
  • 132 exhibitors/booths

The Midyear Clinical Meeting is the longest, continually running clinical pharmacy meeting in the world. This year, against the backdrop of a global pandemic, ASHP promises to bring you an unstoppable Midyear, offering the most timely and relevant content to support contemporary practice and the best possible patient care.

Our 55th meeting brings together our profession’s best and brightest subject matter experts who will share their knowledge about current pharmacy practice in an ever-changing healthcare landscape.

The distribution and administration of the anticipated COVID-19 vaccines are top of mind and on Monday, Dec. 7, ASHP will hold the first of two late-breaking COVID-19 vaccine sessions. Monday’s session will focus on clinical considerations. A second session will be held on Wednesday, with a focus on operational considerations. In addition to the late-breaking vaccine sessions, we have 18 relevant and informative sessions that will keep you up-to-date on the latest developments related to COVID-19 response and recovery.

Monday will also feature a special Town Hall hosted by Paul C. Walker, Pharm.D., FASHP, chair of the ASHP Task Force on Racial Diversity, Equity, and Inclusion. Dr. Walker will present the Task Force’s draft recommendations for new and enhanced efforts ASHP should take to address issues of racial diversity, equity, and inclusion impacting Black, Indigenous and People of Color. The Task Force will consider feedback from the Town Hall and other channels in preparing a final report and recommendations to submit to the ASHP Board of Directors in January 2021.

This year’s Midyear marks the first anniversary of the ASHP Innovation Center. The center seeks to elevate the vital role hospital and health-system pharmacy practitioners play in new and emerging science, and position pharmacy practitioners as influencers in developing systems that advance patient safety and quality care. This year’s Midyear offers a wealth of programming dedicated to implementing and using innovative strategies and solutions to further pharmacy practice, including two critical on-demand sessions: Innovations in Drug Information Practice and Research; and Advanced and Innovative Roles in the Specialty Pharmacy Setting. Later in the week, on Thursday, Dec. 10, we have a session highlighting the pros and cons of new technologies that have improved patient care safety and efficiency.

As part of the ASHP Innovation Center, the ASHP Foundation is currently accepting applications for a competitive grant program to support projects that demonstrate the impact of optimizing health information technology and digital transformation that enhance safe and effective use of medications. The grant program is available for interprofessional healthcare teams with a pharmacist as principal investigator. The deadline for applications is Feb. 4, 2021.

I encourage attendees to check out the ASHP Midyear Virtual Posters. With our virtual platform, you can review poster PDFs and audio clips summarizing each project. Authors will be available for real-time video Q & A chats alongside their virtual posters.

These are just a handful of the highlights from the largest gathering of pharmacists in the world. Be sure to follow us on social media @ASHPOfficial and #ASHP2020 on Twitter, Facebook, Instagram, and LinkedIn, and look for News & Views, the official Midyear newspaper, which will be delivered digitally to all attendees via a daily e-mail. Also, be sure to check out ashptv.com for daily interviews, member stories, and content.

The success of this unstoppable Midyear Clinical Meeting is due to the tremendous work of hundreds of ASHP members and staff, and we are pleased to showcase their efforts and share this event with you.

Finally, I would like to wish all of our members a safe and healthy holiday season. Thank you for being a member of ASHP and for all you do for your patients and our profession during these very challenging times.

Sincerely,

Paul

Older Posts »

Powered by WordPress